AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis
MONDAY, March 18, 2024 -- Lebrikizumab demonstrates improvement in skin clearance and itch relief in patients with skin of color and moderate-to-severe atopic dermatitis, according to a study presented at the annual meeting of the American Academy... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 18, 2024 Category: Pharmaceuticals Source Type: news

Tips on Managing Acne in Transmasculine Patients Tips on Managing Acne in Transmasculine Patients
Testosterone therapy can exacerbate symptoms, and other factors are important to consider, expert said.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - March 18, 2024 Category: Primary Care Tags: Dermatology Source Type: news

Dermatologist reveals how skincare routine can make a difference for over 50s
A skincare expert has issued important advice about anti-ageing products to people over a certain age. (Source: Daily Express - Health)
Source: Daily Express - Health - March 17, 2024 Category: Consumer Health News Source Type: news

Prurigo Nodularis: Nemolizumab Efficacy Persists at 52 Weeks Prurigo Nodularis: Nemolizumab Efficacy Persists at 52 Weeks
The encouraging long-term efficacy and safety associated with nemolizumab (IL-31 inhibitor) in prurigo nodularis was supported by a second set of data showing long-term benefit in atopic dermatitis.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 15, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news

Topical Nonsteroid Gets High Marks for Youngsters With Atopic Dermatitis
(MedPage Today) -- SAN DIEGO -- Once-daily topical therapy for small children with atopic dermatitis (AD) produced rapid improvement with good tolerability, a large randomized trial showed. Evidence of improvement occurred within the first week... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 15, 2024 Category: Dermatology Source Type: news

Derma AI Cureskin bags $20M Series B funding and more funding from India
Also, digital diabetes management startup Sugar.fit secured $5 million more in Series A funding. (Source: mobihealthnews)
Source: mobihealthnews - March 15, 2024 Category: Information Technology Source Type: news

Most Baby Cleansers Are Not'Allergen-Free,' Study Finds Most Baby Cleansers Are Not'Allergen-Free,' Study Finds
A recent study demonstrated that 94% of top-selling baby cleansers contain allergens, despite having hypoallergenic claims.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 15, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news

5 hidden Indian superfoods in your kitchen for radiant skin
Did you know your kitchen holds hidden treasures for glowing skin? Discover five Indian superfoods endorsed by dermatologists. (Source: The Economic Times)
Source: The Economic Times - March 15, 2024 Category: Consumer Health News Source Type: news

How Flesh-Eating Bacteria Destroyed a Fitness Influencer's Life
(MedPage Today) -- In this video, Mikhail Varshavski, DO -- who goes by "Dr. Mike" on social media -- has an in-depth conversation with a fitness influencer infected with Mycobacterium after vitamin B12 shots. Following is a partial transcript... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 15, 2024 Category: Dermatology Source Type: news

Major Responses Seen for Cicatricial and Total Hair Loss Major Responses Seen for Cicatricial and Total Hair Loss
Two oral therapies targeted at kinase pathways produced meaningful responses in patients with severe types of alopecia in late-breaking studies at the American Academy of Dermatology.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 14, 2024 Category: Dermatology Tags: Dermatology Source Type: news

Florida Bill Addresses Coverage of Skin Cancer Screening Florida Bill Addresses Coverage of Skin Cancer Screening
Some 321,000 state employees would be eligible, at a cost of about $357,000 per year, according to one analysis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 14, 2024 Category: Consumer Health News Tags: Dermatology Source Type: news

Short-Term High-Dose Psoriasis Therapy Shows Potential for Long-Term Disease Control
(MedPage Today) -- SAN DIEGO -- Short-term, high-dose treatment with risankizumab (Skyrizi) induced long-term control of plaque psoriasis in association with eradication of resident memory T cells (TRM), a small proof-of-principle study showed... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 13, 2024 Category: Dermatology Source Type: news

2024 AAD Acne Guidelines: Newer Therapies Join Old Standbys 2024 AAD Acne Guidelines: Newer Therapies Join Old Standbys
A coauthor of the new recommendations highlights updated advice and comments on worrisome benzene news.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 13, 2024 Category: Internal Medicine Tags: Dermatology Source Type: news

Mayo Clinic Minute: Can collagen supplements help with aging?
Many people take collagen supplements, hoping to capture the fountain of youth. But can these products really reverse the aging process? Dr. Dawn Davis, a Mayo Clinic dermatologist, weighs in on the issue. Watch: The Mayo Clinic Minute https://youtu.be/kAIE9qFMUbU Journalists: Broadcast-quality video (0:57) is in the downloads at the end of this post. Please courtesy: "Mayo Clinic News Network." Read the script. Scroll through social media, and you're bound to see ads and videos promoting the… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 13, 2024 Category: Databases & Libraries Source Type: news

Lebrikizumab Found Effective for Patients With AD, SOC Lebrikizumab Found Effective for Patients With AD, SOC
Interim results at 16 weeks were based on 50 adolescents and adults with skin types IV-VI.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 12, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news